Human Challenge Trials for a COVID-19 Vaccine
Photo by CDC on Unsplash INTRODUCTION Safe and effective vaccines are yet to be developed and distributed for the treatment of the virus that causes COVID-19. “Vaccine trials are notoriously lengthy, with optimistic estimates of 12 to 18 months to vaccine rollout.”[1] Safe and effective vacci...
Main Author: | Victor Chidi Wolemonwu |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia University Libraries
2020-08-01
|
Series: | Voices in Bioethics |
Subjects: | |
Online Access: | https://journals.library.columbia.edu/index.php/bioethics/article/view/6893 |
Similar Items
-
An Ethical Analysis of the Global Medical Brain Drain
by: Christiana Oshotse
Published: (2019-03-01) -
Non-COVID-19 Patients Left out in the Cold
by: Camille Castelyn
Published: (2020-05-01) -
Global health equity
by: Awele Utomi
Published: (2020-06-01) -
When could human challenge trials be deployed to combat emerging infectious diseases? Lessons from the case of a Zika virus human challenge trial
by: Ricardo Palacios, et al.
Published: (2019-12-01) -
Response to Doctors for Life on assisted suicide
by: C A Joseph
Published: (2024-07-01)